Please assess the completion status of the following clinical trial:

Trial Title: A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Female patients, \> 50 years of age~* Diagnosed osteoporosis~* Bone mineral density \< minus 2.5 SD or osteoporotic fracture~* At least 3 years after menopause~Exclusion Criteria:~* Impaired renal function~* Contra-indication to Calcium or Vitamin D therapy~* Previous or current treatment with biphosphonates

- Gender: FEMALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single Arm (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).